1353567-32-4 Usage
Description
N-Cyclohexyl-6-Methyl-2-[4-(4-Morpholinyl]-iMidazo[1,2-a]pyridin-3-aMine is a complex organic compound with a unique chemical structure. It is characterized by its imidazo[1,2-a]pyridine core, which is fused with a cyclohexyl and a methyl group. Additionally, it features a morpholinyl moiety attached to the imidazo[1,2-a]pyridine ring, contributing to its potential biological activities.
Uses
1. Used in Pharmaceutical Industry:
N-Cyclohexyl-6-Methyl-2-[4-(4-Morpholinyl]-iMidazo[1,2-a]pyridin-3-aMine is used as a 5-lipoxygenase inhibitor for the treatment of inflammatory diseases and cancers. Its ability to inhibit the 5-lipoxygenase enzyme plays a crucial role in reducing inflammation and potentially limiting the progression of cancer cells.
2. Used in Inflammatory Disease Treatment:
N-Cyclohexyl-6-Methyl-2-[4-(4-Morpholinyl]-iMidazo[1,2-a]pyridin-3-aMine is used as an anti-inflammatory agent for the treatment of various inflammatory diseases. By inhibiting the 5-lipoxygenase enzyme, it can help reduce the production of inflammatory mediators, such as leukotrienes, which are involved in the inflammatory response.
3. Used in Cancer Therapy:
N-Cyclohexyl-6-Methyl-2-[4-(4-Morpholinyl]-iMidazo[1,2-a]pyridin-3-aMine is used as a potential therapeutic agent in cancer treatment. Its 5-lipoxygenase inhibitory activity may contribute to the suppression of cancer cell growth and proliferation, making it a promising candidate for further research and development in oncology.
Check Digit Verification of cas no
The CAS Registry Mumber 1353567-32-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,3,5,6 and 7 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1353567-32:
(9*1)+(8*3)+(7*5)+(6*3)+(5*5)+(4*6)+(3*7)+(2*3)+(1*2)=164
164 % 10 = 4
So 1353567-32-4 is a valid CAS Registry Number.
1353567-32-4Relevant articles and documents
SAR-study on a new class of imidazo[1,2-a]pyridine-based inhibitors of 5-lipoxygenase
Hieke, Martina,R?dl, Carmen B.,Wisniewska, Joanna M.,La Buscató, Estel.,Stark, Holger,Schubert-Zsilavecz, Manfred,Steinhilber, Dieter,Hofmann, Bettina,Proschak, Ewgenij
supporting information; experimental part, p. 1969 - 1975 (2012/04/17)
A novel class of 5-lipoxygenase (5-LO) inhibitors characterized by a central imidazo[1,2-a]pyridine scaffold, a cyclohexyl moiety and an aromatic system, is presented. This scaffold was identified in a virtual screening study and exhibits promising inhibi
